Global Diagnostic Radiopharmaceuticals Market Research Report 2020
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Diagnostic Radiopharmaceuticals market is segmented into
The Diagnostic Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Diagnostic Radiopharmaceuticals market report are:
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Diagnostic Radiopharmaceuticals market include:
Segment by Type, the Diagnostic Radiopharmaceuticals market is segmented into
- Technetium 99
- Fluorine 18
- Other
- Diagnostic radiopharmaceuticals are mainly divided into technetium 99, fluorine 18 and others. Among them, technetium 99 accounted for the main part, accounting for about 47.56% of the total market in 2019.
- Oncology
- Cardiology
- Other
- Diagnostic radiopharmaceutical applications are mainly for oncology, cardiology and others. Among them, oncology accounts for the main part, accounting for about 45.8% of the total market in 2019.
The Diagnostic Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Diagnostic Radiopharmaceuticals market report are:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Diagnostic Radiopharmaceuticals market include:
- Cardinal Health
- GE Healthcare
- Curium Pharma
- Jubilant Pharma
- Bracco Imaging
- Advanced Accelerator Applications
- SIEMENS
- China Isotope & Radiation
- Dongcheng Pharmaceutical Group
- Lantheus
- Eli Lilly
1 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET OVERVIEW
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals
1.2 Diagnostic Radiopharmaceuticals Segment by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Technetium
1.2.3 Fluorine
1.2.4 Other
1.3 Diagnostic Radiopharmaceuticals Segment by Application
1.3.1 Diagnostic Radiopharmaceuticals Sales Comparison by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Radiopharmaceuticals Revenue 2015-2026
1.4.2 Global Diagnostic Radiopharmaceuticals Sales 2015-2026
1.4.3 Diagnostic Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
1.5 Diagnostic Radiopharmaceuticals Industry
1.6 Diagnostic Radiopharmaceuticals Market Trends
2 GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
2.2 Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
2.3 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Diagnostic Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Diagnostic Radiopharmaceuticals Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Diagnostic Radiopharmaceuticals Players (Opinion Leaders)
3 DIAGNOSTIC RADIOPHARMACEUTICALS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.3.1 North America Diagnostic Radiopharmaceuticals Sales by Country
3.3.2 North America Diagnostic Radiopharmaceuticals Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Diagnostic Radiopharmaceuticals Sales by Country
3.4.2 Europe Diagnostic Radiopharmaceuticals Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
3.5.2 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Diagnostic Radiopharmaceuticals Sales by Country
3.6.2 Latin America Diagnostic Radiopharmaceuticals Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country
3.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
4.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
4.3 Global Diagnostic Radiopharmaceuticals Price Market Share by Type (2015-2020)
4.4 Global Diagnostic Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
5.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
5.3 Global Diagnostic Radiopharmaceuticals Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN DIAGNOSTIC RADIOPHARMACEUTICALS BUSINESS
6.1 Cardinal Health
6.1.1 Corporation Information
6.1.2 Cardinal Health Description, Business Overview and Total Revenue
6.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Cardinal Health Products Offered
6.1.5 Cardinal Health Recent Development
6.2 GE Healthcare
6.2.1 GE Healthcare Corporation Information
6.2.2 GE Healthcare Description, Business Overview and Total Revenue
6.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.2.4 GE Healthcare Products Offered
6.2.5 GE Healthcare Recent Development
6.3 Curium Pharma
6.3.1 Curium Pharma Corporation Information
6.3.2 Curium Pharma Description, Business Overview and Total Revenue
6.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Curium Pharma Products Offered
6.3.5 Curium Pharma Recent Development
6.4 Jubilant Pharma
6.4.1 Jubilant Pharma Corporation Information
6.4.2 Jubilant Pharma Description, Business Overview and Total Revenue
6.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Jubilant Pharma Products Offered
6.4.5 Jubilant Pharma Recent Development
6.5 Bracco Imaging
6.5.1 Bracco Imaging Corporation Information
6.5.2 Bracco Imaging Description, Business Overview and Total Revenue
6.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Bracco Imaging Products Offered
6.5.5 Bracco Imaging Recent Development
6.6 Advanced Accelerator Applications
6.6.1 Advanced Accelerator Applications Corporation Information
6.6.2 Advanced Accelerator Applications Description, Business Overview and Total Revenue
6.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Advanced Accelerator Applications Products Offered
6.6.5 Advanced Accelerator Applications Recent Development
6.7 SIEMENS
6.6.1 SIEMENS Corporation Information
6.6.2 SIEMENS Description, Business Overview and Total Revenue
6.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 SIEMENS Products Offered
6.7.5 SIEMENS Recent Development
6.8 China Isotope & Radiation
6.8.1 China Isotope & Radiation Corporation Information
6.8.2 China Isotope & Radiation Description, Business Overview and Total Revenue
6.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.8.4 China Isotope & Radiation Products Offered
6.8.5 China Isotope & Radiation Recent Development
6.9 Dongcheng Pharmaceutical Group
6.9.1 Dongcheng Pharmaceutical Group Corporation Information
6.9.2 Dongcheng Pharmaceutical Group Description, Business Overview and Total Revenue
6.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Dongcheng Pharmaceutical Group Products Offered
6.9.5 Dongcheng Pharmaceutical Group Recent Development
6.10 Lantheus
6.10.1 Lantheus Corporation Information
6.10.2 Lantheus Description, Business Overview and Total Revenue
6.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Lantheus Products Offered
6.10.5 Lantheus Recent Development
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Description, Business Overview and Total Revenue
6.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Eli Lilly Products Offered
6.11.5 Eli Lilly Recent Development
7 DIAGNOSTIC RADIOPHARMACEUTICALS MANUFACTURING COST ANALYSIS
7.1 Diagnostic Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
7.4 Diagnostic Radiopharmaceuticals Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Diagnostic Radiopharmaceuticals Distributors List
8.3 Diagnostic Radiopharmaceuticals Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Diagnostic Radiopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Type (2021-2026)
10.2 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Application (2021-2026)
10.3 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Region (2021-2026)
10.4 North America Diagnostic Radiopharmaceuticals Estimates and Projections (2021-2026)
10.5 Europe Diagnostic Radiopharmaceuticals Estimates and Projections (2021-2026)
10.6 Asia Pacific Diagnostic Radiopharmaceuticals Estimates and Projections (2021-2026)
10.7 Latin America Diagnostic Radiopharmaceuticals Estimates and Projections (2021-2026)
10.8 Middle East and Africa Diagnostic Radiopharmaceuticals Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals
1.2 Diagnostic Radiopharmaceuticals Segment by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Technetium
1.2.3 Fluorine
1.2.4 Other
1.3 Diagnostic Radiopharmaceuticals Segment by Application
1.3.1 Diagnostic Radiopharmaceuticals Sales Comparison by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Radiopharmaceuticals Revenue 2015-2026
1.4.2 Global Diagnostic Radiopharmaceuticals Sales 2015-2026
1.4.3 Diagnostic Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
1.5 Diagnostic Radiopharmaceuticals Industry
1.6 Diagnostic Radiopharmaceuticals Market Trends
2 GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
2.2 Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
2.3 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Diagnostic Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Diagnostic Radiopharmaceuticals Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Diagnostic Radiopharmaceuticals Players (Opinion Leaders)
3 DIAGNOSTIC RADIOPHARMACEUTICALS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.3.1 North America Diagnostic Radiopharmaceuticals Sales by Country
3.3.2 North America Diagnostic Radiopharmaceuticals Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Diagnostic Radiopharmaceuticals Sales by Country
3.4.2 Europe Diagnostic Radiopharmaceuticals Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
3.5.2 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Diagnostic Radiopharmaceuticals Sales by Country
3.6.2 Latin America Diagnostic Radiopharmaceuticals Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country
3.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2015-2020)
4.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
4.3 Global Diagnostic Radiopharmaceuticals Price Market Share by Type (2015-2020)
4.4 Global Diagnostic Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
5.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
5.3 Global Diagnostic Radiopharmaceuticals Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN DIAGNOSTIC RADIOPHARMACEUTICALS BUSINESS
6.1 Cardinal Health
6.1.1 Corporation Information
6.1.2 Cardinal Health Description, Business Overview and Total Revenue
6.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Cardinal Health Products Offered
6.1.5 Cardinal Health Recent Development
6.2 GE Healthcare
6.2.1 GE Healthcare Corporation Information
6.2.2 GE Healthcare Description, Business Overview and Total Revenue
6.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.2.4 GE Healthcare Products Offered
6.2.5 GE Healthcare Recent Development
6.3 Curium Pharma
6.3.1 Curium Pharma Corporation Information
6.3.2 Curium Pharma Description, Business Overview and Total Revenue
6.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Curium Pharma Products Offered
6.3.5 Curium Pharma Recent Development
6.4 Jubilant Pharma
6.4.1 Jubilant Pharma Corporation Information
6.4.2 Jubilant Pharma Description, Business Overview and Total Revenue
6.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Jubilant Pharma Products Offered
6.4.5 Jubilant Pharma Recent Development
6.5 Bracco Imaging
6.5.1 Bracco Imaging Corporation Information
6.5.2 Bracco Imaging Description, Business Overview and Total Revenue
6.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Bracco Imaging Products Offered
6.5.5 Bracco Imaging Recent Development
6.6 Advanced Accelerator Applications
6.6.1 Advanced Accelerator Applications Corporation Information
6.6.2 Advanced Accelerator Applications Description, Business Overview and Total Revenue
6.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Advanced Accelerator Applications Products Offered
6.6.5 Advanced Accelerator Applications Recent Development
6.7 SIEMENS
6.6.1 SIEMENS Corporation Information
6.6.2 SIEMENS Description, Business Overview and Total Revenue
6.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 SIEMENS Products Offered
6.7.5 SIEMENS Recent Development
6.8 China Isotope & Radiation
6.8.1 China Isotope & Radiation Corporation Information
6.8.2 China Isotope & Radiation Description, Business Overview and Total Revenue
6.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.8.4 China Isotope & Radiation Products Offered
6.8.5 China Isotope & Radiation Recent Development
6.9 Dongcheng Pharmaceutical Group
6.9.1 Dongcheng Pharmaceutical Group Corporation Information
6.9.2 Dongcheng Pharmaceutical Group Description, Business Overview and Total Revenue
6.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Dongcheng Pharmaceutical Group Products Offered
6.9.5 Dongcheng Pharmaceutical Group Recent Development
6.10 Lantheus
6.10.1 Lantheus Corporation Information
6.10.2 Lantheus Description, Business Overview and Total Revenue
6.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Lantheus Products Offered
6.10.5 Lantheus Recent Development
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Description, Business Overview and Total Revenue
6.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Eli Lilly Products Offered
6.11.5 Eli Lilly Recent Development
7 DIAGNOSTIC RADIOPHARMACEUTICALS MANUFACTURING COST ANALYSIS
7.1 Diagnostic Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
7.4 Diagnostic Radiopharmaceuticals Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Diagnostic Radiopharmaceuticals Distributors List
8.3 Diagnostic Radiopharmaceuticals Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Diagnostic Radiopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Type (2021-2026)
10.2 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Application (2021-2026)
10.3 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Region (2021-2026)
10.4 North America Diagnostic Radiopharmaceuticals Estimates and Projections (2021-2026)
10.5 Europe Diagnostic Radiopharmaceuticals Estimates and Projections (2021-2026)
10.6 Asia Pacific Diagnostic Radiopharmaceuticals Estimates and Projections (2021-2026)
10.7 Latin America Diagnostic Radiopharmaceuticals Estimates and Projections (2021-2026)
10.8 Middle East and Africa Diagnostic Radiopharmaceuticals Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES
Table 1. Global Diagnostic Radiopharmaceuticals Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Diagnostic Radiopharmaceuticals Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Diagnostic Radiopharmaceuticals Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Diagnostic Radiopharmaceuticals Manufacturers Covered in This Study
Table 5. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Diagnostic Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 7. Global Diagnostic Radiopharmaceuticals Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Diagnostic Radiopharmaceuticals Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Diagnostic Radiopharmaceuticals Sales Sites and Area Served
Table 11. Manufacturers Diagnostic Radiopharmaceuticals Product Types
Table 12. Global Diagnostic Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Diagnostic Radiopharmaceuticals Players
Table 16. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Region (2015-2020)
Table 17. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 18. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) by Region (2015-2020)
Table 19. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 20. North America Diagnostic Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 21. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 22. North America Diagnostic Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 24. Europe Diagnostic Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 25. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 26. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 32. Latin America Diagnostic Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 33. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 34. Latin America Diagnostic Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 40. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 41. Global Diagnostic Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 42. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) by Type (2015-2020)
Table 43. Global Diagnostic Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 44. Global Diagnostic Radiopharmaceuticals Price (US$/Unit) by Type (2015-2020)
Table 45. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 46. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 47. Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2015-2020)
Table 48. Cardinal Health Diagnostic Radiopharmaceuticals Corporation Information
Table 49. Cardinal Health Description and Business Overview
Table 50. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. Cardinal Health Main Product
Table 52. Cardinal Health Recent Development
Table 53. GE Healthcare Diagnostic Radiopharmaceuticals Corporation Information
Table 54. GE Healthcare Corporation Information
Table 55. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. GE Healthcare Main Product
Table 57. GE Healthcare Recent Development
Table 58. Curium Pharma Diagnostic Radiopharmaceuticals Corporation Information
Table 59. Curium Pharma Corporation Information
Table 60. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Curium Pharma Main Product
Table 62. Curium Pharma Recent Development
Table 63. Jubilant Pharma Diagnostic Radiopharmaceuticals Corporation Information
Table 64. Jubilant Pharma Corporation Information
Table 65. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Jubilant Pharma Main Product
Table 67. Jubilant Pharma Recent Development
Table 68. Bracco Imaging Diagnostic Radiopharmaceuticals Corporation Information
Table 69. Bracco Imaging Corporation Information
Table 70. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Bracco Imaging Main Product
Table 72. Bracco Imaging Recent Development
Table 73. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Corporation Information
Table 74. Advanced Accelerator Applications Corporation Information
Table 75. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Advanced Accelerator Applications Main Product
Table 77. Advanced Accelerator Applications Recent Development
Table 78. SIEMENS Diagnostic Radiopharmaceuticals Corporation Information
Table 79. SIEMENS Corporation Information
Table 80. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. SIEMENS Main Product
Table 82. SIEMENS Recent Development
Table 83. China Isotope & Radiation Diagnostic Radiopharmaceuticals Corporation Information
Table 84. China Isotope & Radiation Corporation Information
Table 85. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. China Isotope & Radiation Main Product
Table 87. China Isotope & Radiation Recent Development
Table 88. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Corporation Information
Table 89. Dongcheng Pharmaceutical Group Corporation Information
Table 90. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Dongcheng Pharmaceutical Group Main Product
Table 92. Dongcheng Pharmaceutical Group Recent Development
Table 93. Lantheus Diagnostic Radiopharmaceuticals Corporation Information
Table 94. Lantheus Corporation Information
Table 95. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Lantheus Main Product
Table 97. Lantheus Recent Development
Table 98. Eli Lilly Diagnostic Radiopharmaceuticals Corporation Information
Table 99. Eli Lilly Corporation Information
Table 100. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Eli Lilly Main Product
Table 102. Eli Lilly Recent Development
Table 103. Sales Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Diagnostic Radiopharmaceuticals Distributors List
Table 106. Diagnostic Radiopharmaceuticals Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Diagnostic Radiopharmaceuticals Sales (K Units) Forecast by Type (2021-2026)
Table 111. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026)
Table 112. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global Diagnostic Radiopharmaceuticals Sales (K Units) Forecast by Application (2021-2026)
Table 115. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global Diagnostic Radiopharmaceuticals Sales (K Units) Forecast by Region (2021-2026)
Table 117. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 118. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 1. Global Diagnostic Radiopharmaceuticals Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Diagnostic Radiopharmaceuticals Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Diagnostic Radiopharmaceuticals Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Diagnostic Radiopharmaceuticals Manufacturers Covered in This Study
Table 5. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Diagnostic Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 7. Global Diagnostic Radiopharmaceuticals Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Diagnostic Radiopharmaceuticals Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Diagnostic Radiopharmaceuticals Sales Sites and Area Served
Table 11. Manufacturers Diagnostic Radiopharmaceuticals Product Types
Table 12. Global Diagnostic Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Diagnostic Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Diagnostic Radiopharmaceuticals Players
Table 16. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Region (2015-2020)
Table 17. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 18. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) by Region (2015-2020)
Table 19. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 20. North America Diagnostic Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 21. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 22. North America Diagnostic Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 24. Europe Diagnostic Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 25. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 26. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 32. Latin America Diagnostic Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 33. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 34. Latin America Diagnostic Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 40. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 41. Global Diagnostic Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 42. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) by Type (2015-2020)
Table 43. Global Diagnostic Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 44. Global Diagnostic Radiopharmaceuticals Price (US$/Unit) by Type (2015-2020)
Table 45. Global Diagnostic Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 46. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 47. Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2015-2020)
Table 48. Cardinal Health Diagnostic Radiopharmaceuticals Corporation Information
Table 49. Cardinal Health Description and Business Overview
Table 50. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. Cardinal Health Main Product
Table 52. Cardinal Health Recent Development
Table 53. GE Healthcare Diagnostic Radiopharmaceuticals Corporation Information
Table 54. GE Healthcare Corporation Information
Table 55. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. GE Healthcare Main Product
Table 57. GE Healthcare Recent Development
Table 58. Curium Pharma Diagnostic Radiopharmaceuticals Corporation Information
Table 59. Curium Pharma Corporation Information
Table 60. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Curium Pharma Main Product
Table 62. Curium Pharma Recent Development
Table 63. Jubilant Pharma Diagnostic Radiopharmaceuticals Corporation Information
Table 64. Jubilant Pharma Corporation Information
Table 65. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Jubilant Pharma Main Product
Table 67. Jubilant Pharma Recent Development
Table 68. Bracco Imaging Diagnostic Radiopharmaceuticals Corporation Information
Table 69. Bracco Imaging Corporation Information
Table 70. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Bracco Imaging Main Product
Table 72. Bracco Imaging Recent Development
Table 73. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Corporation Information
Table 74. Advanced Accelerator Applications Corporation Information
Table 75. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Advanced Accelerator Applications Main Product
Table 77. Advanced Accelerator Applications Recent Development
Table 78. SIEMENS Diagnostic Radiopharmaceuticals Corporation Information
Table 79. SIEMENS Corporation Information
Table 80. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. SIEMENS Main Product
Table 82. SIEMENS Recent Development
Table 83. China Isotope & Radiation Diagnostic Radiopharmaceuticals Corporation Information
Table 84. China Isotope & Radiation Corporation Information
Table 85. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. China Isotope & Radiation Main Product
Table 87. China Isotope & Radiation Recent Development
Table 88. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Corporation Information
Table 89. Dongcheng Pharmaceutical Group Corporation Information
Table 90. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Dongcheng Pharmaceutical Group Main Product
Table 92. Dongcheng Pharmaceutical Group Recent Development
Table 93. Lantheus Diagnostic Radiopharmaceuticals Corporation Information
Table 94. Lantheus Corporation Information
Table 95. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Lantheus Main Product
Table 97. Lantheus Recent Development
Table 98. Eli Lilly Diagnostic Radiopharmaceuticals Corporation Information
Table 99. Eli Lilly Corporation Information
Table 100. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Eli Lilly Main Product
Table 102. Eli Lilly Recent Development
Table 103. Sales Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Diagnostic Radiopharmaceuticals Distributors List
Table 106. Diagnostic Radiopharmaceuticals Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Diagnostic Radiopharmaceuticals Sales (K Units) Forecast by Type (2021-2026)
Table 111. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026)
Table 112. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global Diagnostic Radiopharmaceuticals Sales (K Units) Forecast by Application (2021-2026)
Table 115. Global Diagnostic Radiopharmaceuticals Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global Diagnostic Radiopharmaceuticals Sales (K Units) Forecast by Region (2021-2026)
Table 117. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 118. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of Diagnostic Radiopharmaceuticals
Figure 2. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type: 2020 VS 2026
Figure 3. Technetium 99 Product Picture
Figure 4. Fluorine 18 Product Picture
Figure 5. Other Product Picture
Figure 6. Global Diagnostic Radiopharmaceuticals Consumption Market Share by Application: 2020 VS 2026
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Other
Figure 10. Global Diagnostic Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 11. Global Diagnostic Radiopharmaceuticals Sales Capacity (K Units) (2015-2026)
Figure 12. Global Diagnostic Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Diagnostic Radiopharmaceuticals Sales Share by Manufacturers in 2020
Figure 14. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Diagnostic Radiopharmaceuticals Revenue in 2019
Figure 16. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 18. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 19. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 20. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 21. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 22. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 23. U.S. Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 28. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 29. Germany Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 40. Asia Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 41. China Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 64. Latin America Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 65. Mexico Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 73. Turkey Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. UAE Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 78. UAE Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Diagnostic Radiopharmaceuticals by Type (2015-2020)
Figure 80. Sales Market Share of Diagnostic Radiopharmaceuticals by Type in 2019
Figure 81. Revenue Share of Diagnostic Radiopharmaceuticals by Type (2015-2020)
Figure 82. Revenue Market Share of Diagnostic Radiopharmaceuticals by Type in 2019
Figure 83. Global Diagnostic Radiopharmaceuticals Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 85. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Diagnostic Radiopharmaceuticals by Application (2015-2020)
Figure 87. Global Revenue Share of Diagnostic Radiopharmaceuticals by Application in 2020
Figure 88. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Curium Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Jubilant Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Advanced Accelerator Applications Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. SIEMENS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Dongcheng Pharmaceutical Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of Diagnostic Radiopharmaceuticals
Figure 101. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
Figure 102. Diagnostic Radiopharmaceuticals Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. North America Diagnostic Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Diagnostic Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Diagnostic Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Diagnostic Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
Figure 1. Picture of Diagnostic Radiopharmaceuticals
Figure 2. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type: 2020 VS 2026
Figure 3. Technetium 99 Product Picture
Figure 4. Fluorine 18 Product Picture
Figure 5. Other Product Picture
Figure 6. Global Diagnostic Radiopharmaceuticals Consumption Market Share by Application: 2020 VS 2026
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Other
Figure 10. Global Diagnostic Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 11. Global Diagnostic Radiopharmaceuticals Sales Capacity (K Units) (2015-2026)
Figure 12. Global Diagnostic Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Diagnostic Radiopharmaceuticals Sales Share by Manufacturers in 2020
Figure 14. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Diagnostic Radiopharmaceuticals Revenue in 2019
Figure 16. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 18. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 19. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 20. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 21. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 22. North America Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 23. U.S. Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 28. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 29. Germany Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 40. Asia Pacific Diagnostic Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 41. China Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 64. Latin America Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 65. Mexico Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 73. Turkey Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. UAE Diagnostic Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 78. UAE Diagnostic Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Diagnostic Radiopharmaceuticals by Type (2015-2020)
Figure 80. Sales Market Share of Diagnostic Radiopharmaceuticals by Type in 2019
Figure 81. Revenue Share of Diagnostic Radiopharmaceuticals by Type (2015-2020)
Figure 82. Revenue Market Share of Diagnostic Radiopharmaceuticals by Type in 2019
Figure 83. Global Diagnostic Radiopharmaceuticals Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 85. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Diagnostic Radiopharmaceuticals by Application (2015-2020)
Figure 87. Global Revenue Share of Diagnostic Radiopharmaceuticals by Application in 2020
Figure 88. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Curium Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Jubilant Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Advanced Accelerator Applications Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. SIEMENS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Dongcheng Pharmaceutical Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of Diagnostic Radiopharmaceuticals
Figure 101. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
Figure 102. Diagnostic Radiopharmaceuticals Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. North America Diagnostic Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Diagnostic Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Diagnostic Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Diagnostic Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Diagnostic Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
